AVTX
Avalo Therapeutics, Inc.Healthcare$14.16
▲ Bullish
Mkt Cap: $322.7M|Float: 17.3M|SI: 23.6%|DTC: 6.6
Data as of market close Mar 30, 2026
IV Rank
77
IV Pctl
71%
HV 20d
4247.0%
52W Range
$3-$21
ATR(14)
$1.04
Exp. Move
±50.9%
P/C Ratio
0.30
Earnings
-
GEX Positive
DEX Long
Net Call Premium
IV High
Max Pain Above
Exp. Move Wide
Low Put/Call
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 18 | ±$7.20 | ±50.9% | $6.96 | $21.36 |
| 2026-05-15 | 46 | ±$12.50 | ±88.3% | $1.66 | $26.66 |
| 2026-06-18 | 80 | ±$14.05 | ±99.2% | $0.11 | $28.21 |
| 2026-08-21 | 144 | ±$15.50 | ±109.5% | $-1.34 | $29.66 |
| 2026-11-20 | 235 | ±$6.50 | ±45.9% | $7.66 | $20.66 |
Explore AVTX options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.